Skip to main content

Table 4 Three compounds identified as treatment options for GC by CMap analysis

From: Identification of circRNA–miRNA–mRNA networks contributes to explore underlying pathogenesis and therapy strategy of gastric cancer

CMap name

Mean

n

Enrichment

p

Specificity

Percent non-null

Vorinostat

− 0.634

12

− 0.727

0

0.0708

100

Astemizole

− 0.621

5

− 0.766

0.00134

0.0495

100

Trichostatin A

− 0.443

182

− 0.404

0

0.3564

71